Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NCX 4016

Known as: NCX-4016 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Acetylsalicylic acid (ASA) prevents thromboembolic events by inhibiting platelet function through blocking of cyclooxygenase type… Expand
Highly Cited
2006
Highly Cited
2006
Ovarian cancer is a gynecological malignancy that is commonly treated by cytoreductive surgery followed by cisplatin treatment… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Review
2006
Review
2006
NCX 4016, 2-(acetyloxy)benzoic acid 3-[(nitrooxy)methyl]phenyl ester, is a new molecule in which a nitric oxide (NO)-releasing… Expand
2004
2004
The metabolic fate of nitric oxide (NO) released from nitroaspirin, benzoic acid, 2-(acetyloxy)-3-[(nitrooxy)methyl]phenyl ester… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2003
Highly Cited
2003
BACKGROUND AND AIMS NCX-4016 is a nitric oxide-releasing derivative of aspirin with antiplatelet activity. The aim of this study… Expand
Highly Cited
2002
Highly Cited
2002
Background—NCX-4016 is an acetylsalicylic acid (ASA) derivative containing a nitric oxide–releasing moiety. Compared with ASA… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 5
  • figure 4
2002
2002
We investigated the effect of a nitric oxide (NO)‐releasing derivative of aspirin (NCX‐4016) on a mitochondria‐dependent model of… Expand
Highly Cited
2001
Highly Cited
2001
NCX 4016, a nitro-ester of aspirin endowed with antithrombotic activity, appears to have clinical potential in treating cardiac… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
1999
Highly Cited
1999
entirely attributable to the nitric oxide released from the compound, as it was found to be completely devoid of any inhibitory… Expand
Highly Cited
1999
Highly Cited
1999
: Nitric oxide (NO)‐releasing NSAIDs are a new class of NSAID derivatives with markedly reduced gastrointestinal toxicity… Expand